FerdinandSLeyaMD

PubMed

• 21 citations
  Outcomes of Bare Metal versus Drug-eluting Stents in Allograft Vasculopathy
  Proddutur R. Reddy, Akhil Gulati, Lowell Steen, James Sinacore, Ferdinand Leya
  The Journal of Heart and Lung Transplantation. 2008-11-01
• 137 citations
  Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: Results of...
  Christopher P. Cannon, Carolyn H. McCabe, Daniel J. Diver, Steve Herson, Robert M. Greene
  Journal of the American College of Cardiology. 1994-12-01
• 484 citations
  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease
  Eric J. Topol, Ferdinand Leya, Cass A. Pinkerton, Patrick L. Whitlow, Berthold Höfling
  The New England Journal of Medicine. 1993-07-22

Journal Articles

• Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy  
  Sherif F. Nagueh, MD, Bertron M. Groves, MD, Leonard Schwartz, MD, Karen M. Smith, MD, Andrew Wang, MD, Richard G. Bach, MD, Christopher Nielsen, MD, Ferdinand Leya, M..., Journal of American College of Cardiology, 1/1/2011
• Long-Term Outcomes of Plaque Debulking with Rotational Atherectomy in Side-Branch Ostial Lesions to Treat Bifurction Coronary Disease  
  Hiroki Ito, MD, MS, Sheri Piel, MD, Pranab Das, MD, Vikram Chokar, MD, Ghazanfar Khadim, MD, Robert Nierzwicki, MD, Alexis Willimas, MD, Robert S. Dieter, MD, RVT, Fre..., J Invasive Cardiology, 1/1/2009
• Presentation of an Anomalous Origin of the Left Coronary Artery from the Pulmonary Artery: Case Report and Review  
  Ravi K. Ramana, DO, Peter Varga, MD, Ferdinand Leya, MD, J Invasive Cardiology, 1/1/2008
• Regional Variation in the Reconstitution of Flow in the Internal Mammary Artery Graft  
  Proddutur R. Reddy, MD, Mamdouh Bakhos, MD, and Ferdinand Leya, MD, J Cardiac Surgery, 1/1/2008
• Femoral Angiogram Prior to Arteriotomy Closure Device Does Not Reduce Vascular Complications in Patients Undergoing Cardiac Catheterization  
  Ravi K. Ramana, D.O., Amandeep Singh, M.D., Robert S. Dieter, M.D., R.V.T., John F. Moran, MD, Lowell Steen, MD, Bruce E. Lewis, MD, and Ferdinand Leya, MD, Journal of Interventional Cardiology, 1/1/2008
• Utility of BNP in Differentiating Constrictive Pericarditis from Restrictive Cardiomyopathy in Patients with Renal Insufficiency  
  Proddutur R. Reddy, MD, Robert S. Dieter, MD, RVT, Pranab Das, MD, Lowell H. Steen, MD, Bruce E. Lewis, MD, Ferdinand S. Leya, MD, Journal of Cardiac Failure, 1/1/2007
• Ethanol Septal Ablation for Refractory Ventricular Tachycardia  
  Ravi K. Ramana, DO, David J. Wilber, MD, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2007
• Invasive Assessment of Mitral Regurgitation: Comparison of Hemodynamic Parameters  
  Jeffrey H. Freihage, MD, Dominiqe Joyal, MD, Dinesh Arab, MD, Robert S. Dieter, MD, Ferdinand Leya, MD, et al, Catheterization and Cardiovascular Interventions, 1/1/2007
• Clinical Experience with Rotational Atherectomy in Patients with Severe Left Ventricular Dysfunction  
  Ravi K. Ramana, DO, Dominique Joyal, MD, Dinesh Arab, MD, Robert S. Dieter, MD, RVT, Lowell Steen, MD, Bruce Lewis, MD, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2006
• Effects of Argatroban Therapy, Demographic Variables, and Platelet Count on Thrombotic Risks in Heparin-Induced Thrombocytopenia  
  Bruce E. Lewis, MD, Diane E. Wallis, MD, Marcie J. Hursting, PhD, Robert L. Levine, MD, Fred Leya, MD, Chest, 1/1/2006
• Amelioration of Hypertrophic Cardiomyopathy Using Nonsurgical Septal Ablation in a Cirrhotic Patient Prior to Liver Transplantation  
  Anil S. Paramesh, Rapph B. Fairchild, Theresa M. Quinn, Fred Leya, Magdalene George, and David H. Van Thiel, Liver Transplantation, 1/1/2005
• Use of Lepirudin During Percutaneous Vascular Interventions in Patients with Heparin-Induced Thrombocytopenia  
  Harry L. Messmore, Jr. MD, Walter P. Jeske, PhD, William Wehrmacher, MD, Erwin Coyne, PhD, Sohrab Mobarhan, MD, Leslie Cho, MD, Fred S. Leya, MD, John F. Moran, MD, Hematol Oncol Clin N Am, 1/1/2005
• Black Aorta: A Rare Finding at Aortic Valve Replacement  
  Ross J. Goodfellow, MD, Jeffrey Schwartz, MD, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2005
• The Efficacy of Brain Natriuretic Peptide Levels in Differentiating Constrictive Pericarditis From Restrictive Cardiomyopathy  
  Ferdinand Leya, Dinesh Arab, Leslie Cho, Bruce E. Lewis, Lowell H. Steen, Jr., Loyola University Medical Center, JACC, 1/1/2005
• Controlled Myocardial Infarction Induced by Intracoronary Injection of N-Butyl Cyanoacrylate in Dogs: A Feasibility Study  
  Gabor F. Matos, MD, Rasheed Hammadeh, MD, Christopher Francois, MD, Richard McCarthy, MD, and Ferdinand Leya, MD, Catheterization and Cardiovascular Interventions, 1/1/2005
• Antiplatelet Therapy in Anticoagulated Patients Requiring Coronary Intervention  
  Dinesh Arab, MD, Bruce Lewis, MD, Leslie Cho, MD, Lowell Steen, MD, Dominique Joyal, MD, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2005
• Coronary Artery Perforation During Percutaneous Coronary Intervention: Incidence and Outcomes in the New Interventional Era  
  Ravi K. Ramana, DO, Dinesh Arab, MD, Dominique Joyal, MD, Lowell Steen, MD, Leslie Cho, MD, Bruce Lewis, MD, Jayson Liu, MD, Henry Loeb, MD, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2005
• Use of Lepirudin During Percutaneous Vascular Interventions in Patients with Heparin-Induced Thrombocytopenia  
  Kevin Cochran, MD, Tony J. DeMartini, MD, Bruce E. Lewis, MD, James O'Brien, RN, Lowell H. Steen, MD, Eric D. Grassman, MD, Ph.D, Ferdinand Leya, MD, The Journal of Invasive Cardiology, 1/1/2003
• Argatroban Anticoagulation in Patients with Heparin-Induced Thrombocytopenia  
  Bruce E. Lewis, Diane E. Wallis, Fred Leya, Marcie J. Hursting, John G. Kelton, Arch Intern Medicine, 1/1/2003
• New Catheter Design for Cannulation of the Anomalous Right Coronary Artery Arising From the Left Sinus of Valsalva  
  Fred Leya, Usman Qayyum, MD; MD; Lowell Steen, MD; Miroslaw Sochanski, MD; Eric Grassman, MD; Leslie Cho, MD; Bruce Lewis, MD, Catheterization and Cardiovascular Interventions, 1/1/2003
• Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention  
  Steven R. Steinhubl, MD; Peter B. Berger, MD; Eric J. Topol, MD, et al for the CREDO Investigators (Fred Leya, MD, PI for Loyola University Medical Center), JAMA, 1/20/2002
• Argatroban Anticoagulation During Percutaneous Coronary Intervention In Patients With Heparin-Induced Thrombocytopenia  
  Bruce E. Lewis, William H. Matthai, Jr., Marc Cohen, Jeffrey W. Moses, Marcie J. Hursting, Fred Leya for the ARG-216/310/311 Study Investigators, Catheterization and Cardiovascular Interventions, 1/1/2002
• A Randomized Trial of the Low Molecular-Weight Heparin Certoparin to Prevent Restenosis Following Coronary Angioplasty  
  Fred Leya, Eric Grassman, et al, The Journal of Invasive Cardiology, 1/1/2001
• Clinical Experience with Combined Treatment of Thrombin Inhibitors and GP IIb/IIIa Inhibitors in Patients with HIT  
  Jeanine M. Walenga, Walter P. Jeske, Diane E. Wallis, Mamdouh Bakhos, Bruce E. Lewis, Fred Leya, Jawed Fareed, Seminars in Thrombosis and Hemostasis, 1/1/1999
• Combined Thrombin and Platelet Inhibition Treatment for HIT Patients  
  Jeanine M. Walenga, B.E. Lewis, W.P. Jeske, F. Leya, Diane E. Wallis, M. Bakhos, J. Fareed, Hemostaseologie, 1/1/1999
• Join now to see all

Books/Book Chapters

• 1001 Questions: An Interventional Cardiology Board Review. 
  Chapter: Management of Intraprocedural and Postprocedural Complications. 
  Debabrata Mukherjee, MD, Leslie Cho, MD, Fred Leya, MD, et alLippincott Williams & Wilkins2012
• Interface of Neurology and Internal Medicine 
  Chapter: Coronary Artery Disease 
  Jose Biller, MD, Fred Leya, MD, et alLippincott Williams & Wilkins2007
• Interface of Neurology and Internal Medicine 
  Chapter: Acquired Valvular Heart Disease 
  Jose Biller, MD, Fred Leya, MD, et alLippincott Williams & Wilkins2007
• 900 Questions: An Interventional Cardiology Board Review 
  Debabrata Mukherjee, MD, Leslie Cho, MD, David Moliterno, MD, Fred Leya, MD, et alLippincott Williams & Wilkins2006
• Textbook of Interventional Cardiovascular Pharmacology 
  Chapter: Brachytherapy 
  Ramana, Ravi K, DO; Leya Ferdinand, MD; Lewis, Bruce E, MDEditors: Kipshidze, Fareed, Moses & Serruys.Taylor & Francis Books, Ltd2006
• Evidence-based Management of the Acute Coronary Syndrome 
  Roque Pifarre, MD, Patrick J. Scanlon, MD, Fred S. Leya, MD, et alHanley & Belfus, Inc., Medical Publishers2001
• ACC Cardiology Board Certification Review Guide 
  Chapter: Interventional Cardiology (Contributor) 
  Leys FS1999
• Right Ventricle; The Neglected Neighbor of the Left 
  Chapter: Right Ventricular Infarction 
  Dries DJ, Mathru MRG Landes Co., Austin, TX1994
• Drug Therapy in Dilated Cardiomyopathy and Myocarditis 
  Chapter: Is Digitalis Beneficial in Congestive Heart Failure Secondary to Dilated Cardiomyopathy? 
  Leya FS, Gunnar REditors: Englemeier R, O'Connell JB.Marcel Dekker1988
• Join now to see all

Abstracts/Posters

• Safety and Feasibility of Rotational Atherectomy in Elderly Patients with Calcific Left Main Coronary Artery (LMCA) Disease undergoing PCI: A Retrospective Observation...
  Falak Shah, Mahmoud Khreis, Mohamad Hani Lababidi, Amani Sharma, Amir Darki, Bruce E. Lewis, Ferdinand Leya, John J. Lopez, Lowell H. Steen, Jr., 12th Annual Complex Cardiovascular Catheter Therapeutics (C3): Advanced Endovascular and Coronary Intervention Global Summit, Orlando, FL, 1/28/2016
• The Utility of Ankle-Brachial Index (ABI) in Risk Stratifying Patients Undergoing Evaluation for Coronary Artery Disease (CAD).
  Falak Shah, Jessica Pillarella, Robert S. Dieter, Bruce E. Lewis, Ferdinand Leya, John J. Lopez, Conner O'Keefe, Ivan V. Pacold, Lowell H. Steen, Jr., Ami Darki, SCAI 2016 Scientific Session, 1/1/2016
• Can Ccta Derived Lvot Area Reclassify Aortic Stenosis Using the Continuity Equation?
  Rajeev Ruben Fernando, Taishi, Hirai, Syed, MushabbarA., Leya, Fred Sanagala, Thriveni, Dajani, Khaled A, 1/1/2015
• Impact of Percutaneous Cor9onary Intervention on Ventricular Function in Potential Candidates for Prophylactic Implantable Defibrillators.
  Ramana RK, Diter RS, Cohoon KP, Cytron J, Quadar N, Homan D, Steen L, Lewis BE, Leya, F and Wilber DJ, Scientific Sessions of the American Heart Association, 1/1/2008
• Major Arrhythmic Events following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
  William Spear, MD, Hiroki Ito, MD, Jeffrey Freihage, MD, Junaid Ahmed, MD, David Wilber, MD, Fred Leya, MD, Peter Santucci, MD, Heart Rhythm, 1/1/2008
• Invasive Assessment of Mitral Regurgitation: Comparison of Eight Hemodynamic Parameters.
  Jeffrey H. Freihage, Dominique Joyal, Dinesh Arab, Robert S. Dieter, Ferdinand Leya, SCAI, 1/1/2006
• The New Diagnostic Role of Brain Natriuretic Peptide in the Differentiation of Constrictive Pericarditis From Restrictive Cardiomyopathy.
  Ferdinand Leya, Dinesh Arab, Leslie Cho, Bruce E. Lewis, Lowell H. Steen, Jr., ACC, 1/1/2005
• Increased Nitric Oxide Levels With Brachytherapy Compared To Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis. Accepted at AHA as a poster p...
  Omar Iqbal, Daniel Fareed, Walter Jeske, Fred Leya, Jeanine Walenga, Debra Hoppensteadt, Jawed Fareed, AHA Scientific Sessions, 1/1/2004
• Sirolimus Coated Stents Induce a Weaker Inflammatory Response Than Bare-Metal Stents.
  W. Jeske, G. Maszak, T. DeMartini, O. Iqbal, L. Cho, B. Lewis, F. Leya, J.M. Walenga, AHA Scientific Sessions, 1/1/2004
• C-Reactive Protein Levels Following Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Bare Metal Stents.
  Gary J Maszak, Tony DeMartini, Walter Jeske, Leslie Cho, Lowell H. Steen, Bruce E. Lewis, Ferdinand Leya, AHA Scientific Sessions, 1/1/2004
• Comparison of Three Direct Thrombin Inhibitors in Patients with Heparin-Induced Thrombocytopenia Undergoing Percutaneous Intervention.
  Lewis BE, DeMartini TJ, Cochran KJ, Grassman ED, Steen LH, O'Brien JW, Wrona L, Leya F, 5th ICCAD - International Congress on Coronary Artery Disease, Florence, Italy, 1/1/2003
• Platelet and Inflammatory Changes Induced by Angioplasty and Brachytherapy.
  Walter P. Jeske, Rohit Sundrani, Jacqueline Saulters, Bruce E. Lewis, Lowell H. Steen, Mirek Sochanski, Ferdinand Leya, Eric D. Grassman, Jeanine M. Walenga, AHA, 1/1/2002
• Soluble Thrombomodulin is Upregulated in Patients with ACS: Downregulation by LMWH.
  Florian M, Mayuga M, Hoppensteadt DA, Keriakes DJ, Leya F, Lewis BE, et al, ASH, Orlando, FL, 1/1/2001
• Incidence of Cardiovascular Abnormalities in Liver Transplant Candidates.
  Fundador L. Adajar, Ferdinand Leya, David VanThiel, Krystyna Malinowska, et al, Illinois Chapter, ACC Clinical and Research Prize Competition, 1/1/2001
• Differential Behavior of Anti-Xa Adjusted Low Molecular Weight Heparins in Native Whole Blood Analysis as Performed by Thrombolelastography and Activated Clotting Time.
  Iqbal O, Hoppensteadt DA, Lewis BE, Leya F, Ma Q, Fareed J, Blood, 1/1/2000
• Comparison of Saphenous Vein and Internal Mammary Artery Graft Patency in Patients with Heparin-Induced Thrombocytopenia.
  Jayson C. Liu, Bruce E. Lewis, Lowell H. Steen, Eric D. Grassman, Ferdinand Leya, et al, ACC 49th Annual Scientific Session, 1/1/1999
• Loyola University Medical Center, Division of Cardiology, Maywood, IL. Use of Vascular Sealing Devices (Vasoseal and Perclose) Versus Manual Compression (Femostop) in ...
  JR Chamberlin, AB Lardy, LS McKeever, MH Hwang, G. Ramadurai, P. Grunenwald, WP Towne, ED Grassman, FS Leya, BE Lewis, LH Steen, The Society for Cardiac Angiography and Interventions - 21st Annual Meeting, 1/13/1998
• The Low Molecular Weight Heparin Certoparin May Significantly Prevent Restenosis Following Balloon Coronary Angioplasty.
  Eric D Grassman, Fred S Leya, Bruce E Lewis, Loyola University, Maywood, IL, et al, AHA, 70th Scientific Sessions, Orange County Convention Center, Orlando, FL, 1/9/1997
• Results of Phase 2/3 Trial of Argatroban Anticoagulation during PTCA of Patients with Heparin-Induced Thrombocytopenia (HIT).
  Bruce E. Lewis, Loyola University, Maywood, IL; William Matthai, Cooper Hospital, Campton, NJ; Eric D Grassman, Fred S Leya, Jawed Fareed, et al, AHA, 70th Scientific Sessions, Orange County Convention Center, Orlando, FL, 1/9/1997
• A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial).
  Brener SJ, Leya FS, Apperson-Hansen C, Cowley MJ, Califf RM, Topol EJ, Am J Cardiol, 1/1/1996
• Evaluation of hemostatic and fibrinolytic alterations associated with daily administration of low-molecular-weight heparin for a 12-week period.
  Lojewski B, Bacher P, Iqbal O, Walenga JM, Hoppensteadt D, Leya F, Fareed J, Seminars in Thrombosis & Hemostasis, 1/1/1995
• Substitution of a low molecular weight heparin (Mono-Embolex) as an anticoagulant in simulated protocol for PTCA and post PTCA restenosis prevention in primates.
  Lojewski B, Bacher P, Iqbal O, Ovsepian A, Walenga JM, Hoppensteadt D, Leya F, Fareed J, The fifth international symposium, Cambridge, 1/1/1994
• Substitution of a low molecular weight heparin (Mono-Embolex) as an anticoagulant in simulated protocol for PTCA and post PTCA restenosis prevention in primates.
  Lojewski B, Bacher P, Iqbal O, Ovsepian A, Walenga JM, Hoppensteadt D, Leya F, Fareed J, The Cleveland Clinic Foundation Restenosis Summit VI, Cleveland, OH, 1/1/1994
• Clinical and Procedural Variables Associated With Successful PTCA Using Coronary Perfusion Balloon Catheters.
  Grassman ED, Johnson SA, Leya FS, Killian DM, Scanlon PJ, Loyola University Medical Center, 16th Annual Meeting of Society For Cardiac Angiography and Interventions, 1/18/1993
• Hemostatic profile of a three months daily subcutaneous treatment with LMW Heparin.
  Bacher P, Lojewski B, Iqbal O, Walenga JM, Leya F, Wolf H, Welzel D, Fareed J, XIVth Congress of the International Society on Thrombosis and Haemostasis, New York, NY, 1/1/1993
• Join now to see all

Lectures

• Effect of Cardiopulmonary Support on Regional and Global LV Function During Transient Coronary Occlusion. 
  1/1/1991

Other

• Toxicological and safety aspects of Low Molecular Weight Heparin (Sandoparin (R)) used over a 12 week period with daily subcutaneous administration in subhuman primates. 
  Bacher P, Lojewski B, Iqbal O, Hoppensteadt D, Walenga JM, Leya F, Pifarre R, Fareed J, FDA